Literature DB >> 28159538

The effect of systemic lipoic acid on hearing preservation after cochlear implantation via the round window approach: A guinea pig model.

Mun Young Chang1, Tae Mok Gwon2, Ho Sun Lee3, Jun Ho Lee4, Seung Ha Oh4, Sung June Kim2, Min-Hyun Park5.   

Abstract

The present study aimed to evaluate the effects of systemic lipoic acid on hearing preservation after cochlear implantation. Twelve Dunkin-Hartley guinea pigs were randomly divided into two groups: the control group and the lipoic acid group. Animals in the lipoic acid group received lipoic acid intraperitoneally for 4 weeks. A sterilised silicone electrode-dummy was inserted through the round window to a depth of approximately 5 mm. The hearing level was measured using auditory brainstem responses (ABRs) prior to electrode-dummy insertion, and at 4 days and 1, 2, 3 and 4 weeks after electrode-dummy insertion. The threshold shift was defined as the difference between the pre-operative threshold and each of the post-operative thresholds. The cochleae were examined histologically 4 weeks after electrode-dummy insertion. Threshold shifts changed with frequency but not time. At 2kHz, ABR threshold shifts were statistically significantly lower in the lipoic acid group than the control group. At 8, 16 and 32kHz, there was no significant difference in the ABR threshold shift between the two groups. Histologic review revealed less intracochlear fibrosis along the electrode-dummy insertion site in the lipoic acid group than in the control group. The spiral ganglion cell densities of the basal, middle and apical turns were significantly higher in the lipoic acid group compared with the control group. Therefore, systemic lipoic acid administration appears to effectively preserve hearing at low frequencies in patients undergoing cochlear implantation. These effects may be attributed to the protection of spiral ganglion cells and prevention of intracochlear fibrosis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cochlear implantation; Hearing preservation; Lipoic acid; Residual hearing

Mesh:

Substances:

Year:  2017        PMID: 28159538     DOI: 10.1016/j.ejphar.2017.01.042

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.

Authors:  Daniele Tibullo; Giovanni Li Volti; Cesarina Giallongo; Sonia Grasso; Daniele Tomassoni; Carmelina Daniela Anfuso; Gabriella Lupo; Francesco Amenta; Roberto Avola; Vincenzo Bramanti
Journal:  Inflamm Res       Date:  2017-07-04       Impact factor: 4.575

2.  A New Approach to Treating Neurodegenerative Otologic Disorders.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2018-07-01

3.  Safety and Efficacy of Intratympanic Alpha-Lipoic Acid Injection in a Mouse Model of Noise-Induced Hearing Loss.

Authors:  Jae Sang Han; Ye Lin Kim; Hyo Jeong Yu; Jung Mee Park; Yeonji Kim; So Young Park; Shi Nae Park
Journal:  Antioxidants (Basel)       Date:  2022-07-22

Review 4.  The Use of Nanoparticles in Otoprotection.

Authors:  Maurizio Barbara; Valerio Margani; Edoardo Covelli; Chiara Filippi; Luigi Volpini; Ola M El-Borady; Maged El-Kemary; Saad Elzayat; Haitham H Elfarargy
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

Review 5.  Advances in hearing preservation in cochlear implant surgery.

Authors:  Osama Tarabichi; Megan Jensen; Marlan R Hansen
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2021-10-01       Impact factor: 1.814

6.  An Antioxidant Screen Identifies Candidates for Protection of Cochlear Hair Cells from Gentamicin Toxicity.

Authors:  Volker Noack; Kwang Pak; Rahul Jalota; Arwa Kurabi; Allen F Ryan
Journal:  Front Cell Neurosci       Date:  2017-08-18       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.